Drug Information

Drug General Information
Drug ID
D08MON
Former ID
DNC013873
Drug Name
3-Benzyl-5-methoxy-7-methylchromen-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530009]
Formula
C18H16O3
Canonical SMILES
CC1=CC2=C(C=C(C(=O)O2)CC3=CC=CC=C3)C(=C1)OC
InChI
1S/C18H16O3/c1-12-8-16(20-2)15-11-14(18(19)21-17(15)9-12)10-13-6-4-3-5-7-13/h3-9,11H,10H2,1-2H3
InChIKey
AOPKGUPAQXHRKK-UHFFFAOYSA-N
PubChem Compound ID
16067266
Target and Pathway
Target(s) Cannabinoid receptor 1 Target Info Inhibitor [530009]
KEGG Pathway Rap1 signaling pathway
Neuroactive ligand-receptor interaction
Retrograde endocannabinoid signaling
PANTHER Pathway Endogenous cannabinoid signaling
Pathway Interaction Database N-cadherin signaling events
Reactome Class A/1 (Rhodopsin-like receptors)
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Small Ligand GPCRs
BDNF signaling pathway
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.
Ref 530009Bioorg Med Chem. 2009 Apr 1;17(7):2842-51. Epub 2009 Feb 21.Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists.